Literature DB >> 28749077

MiR-429 suppresses glioblastoma multiforme by targeting SOX2.

Huixiao Dong1, Xiuzhen Hao1, Benliang Cui1, Meiling Guo1.   

Abstract

Accumulating evidence has shown that miR-429 plays an important role in the development and progression of tumour. However, the role of miR-429 in glioblastoma multiforme (GBM) remains largely unknown. The present study is designed to investigate the function of miR-429 in GBM and to explore the molecular mechanism underlying its function. The expression level of miR-429 was detected in GBM tissues and cell lines by quantitative real-time polymerase chain reaction. The effect of overexpression of miR-429 on in vitro cell proliferation, apoptosis and invasion was examined. Western blot analysis was used to detect the influence of miR-429 on the expression of target gene, and Pearson analysis was used to calculate the correlation between the expression of targets gene and the miR-429 in GBM tissues. Our study shows that miR-429 is downregulated in GBM tissues compared with noncancerous tissues (P < .01). In addition, the expression of miR-429 in GBM cell lines is also significantly lower (P < .01). Enforced expression of miR-429 inhibits GBM cells proliferation, induces apoptosis and suppresses invasion and leads to the downregulation of the SOX2 protein. Moreover, the expression level of miR-429 in GBM tissues shows inverse relationship with the expression level of SOX2 protein. Our findings suggest that miR-429 represents a potential tumour-suppressive miRNA and plays an important role in GBM progression by directly targeting SOX2.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  SOX2; glioblastoma multiforme; miR-429

Mesh:

Substances:

Year:  2017        PMID: 28749077     DOI: 10.1002/cbf.3271

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  16 in total

1.  Identification of MSC-AS1, a novel lncRNA for the diagnosis of laryngeal cancer.

Authors:  Yudong Liu; Wenxia Meng; Huan Cao; Baoshan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-20       Impact factor: 2.503

2.  The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.

Authors:  Fatemeh Gheidari; Ehsan Arefian; Fatemeh Saadatpour; Mahboubeh Kabiri; Ehsan Seyedjafari; Ladan Teimoori-Toolabi; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2022-10-11       Impact factor: 2.742

3.  LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway.

Authors:  Liping Wu; Yongcun Liu; Cheng Guo; Yuan Shao
Journal:  Cancer Cell Int       Date:  2020-07-09       Impact factor: 5.722

4.  LncRNA SOX2OT affects cervical cancer cell growth, migration and invasion by regulating SOX2.

Authors:  Xiaohan Chang; Huijie Zhang; Qing Yang; Li Pang
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

5.  Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.

Authors:  Taoqiong Li; Li Lin; Qin Liu; Wujiang Gao; Lu Chen; Chunli Sha; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

6.  Dexmedetomidine attenuates cisplatin-induced cognitive impairment by modulating miR-429-3p expression in rats.

Authors:  Chang Li; Jiangfeng Niu; Bin Zhou; Wei Deng; Fumou Deng; Zhidong Zhou; Guohai Xu
Journal:  3 Biotech       Date:  2020-05-10       Impact factor: 2.406

7.  Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.

Authors:  Ke Zhou; Chi Zhang; Hui Yao; Xuewen Zhang; Youxin Zhou; Yanjun Che; Yulun Huang
Journal:  Mol Cancer       Date:  2018-07-27       Impact factor: 27.401

8.  miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.

Authors:  Zhihui Wang; Zhiquan Zhu; Zhong Lin; Youli Luo; Zibin Liang; Caibin Zhang; Jianxu Chen; Peijian Peng
Journal:  Cancer Cell Int       Date:  2019-04-30       Impact factor: 5.722

9.  SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer.

Authors:  Peng Liu; Hailin Tang; Cailu Song; Jin Wang; Bo Chen; Xiaojia Huang; Xiaoqing Pei; Longzhong Liu
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

Review 10.  The miR-200 family: multiple effects on gliomas.

Authors:  Lilei Peng; Jie Fu; Yang Ming
Journal:  Cancer Manag Res       Date:  2018-07-13       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.